|
Market Cap | 1.47B | EPS (ttm) | 2.69 |
P/E | 16.12 | EPS this Y | -17.29% |
Forward P/E | 10.58 | EPS next Y | 31.83% |
PEG | - | EPS past 5Y | 4.99% |
P/S | 0.09 | EPS next 5Y | - |
P/B | 2.37 | EPS Q/Q | -153.26% |
Dividend | 6.69% | Sales Q/Q | 2.85% |
Insider Own | 14.48% | Inst Own | 37.99% |
Insider Trans | 1.61% | Inst Trans | 1.23% |
Short Float | 3.45% | Earnings | May 08/b |
Analyst Recom | 2.00 | Target Price | 50.00 |
Avg Volume | 89.15K | 52W Range | 27.07 - 49.50 |
|
|
|
Global Partners LP engages in purchasing, selling, storing, and the logistics of transporting petroleum and related products. It operates through the following business segments: Wholesale, Gasoline Distribution and Station Operations (GDSO), and Commercial. The Wholesale segment sells branded and unbranded gasoline and gasoline blendstocks and diesel to wholesale distributors. The GDSO segment includes the sale of branded and unbranded gasoline to gasoline station operators and sub jobbers. The Commercial segment refers to the sales and deliveries to end user customers in the public sector and to large commercial and industrial end users of unbranded gasoline, home heating oil, diesel, kerosene, residual oil, bunker fuel, and natural gas. The company was founded in March 2005 and is headquartered in Waltham, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Global GP LLC | General Partner | May 15 '24 | Buy | 43.29 | 10,000 | 432,900 | 47,981 | May 15 05:30 PM | Global GP LLC | General Partner | May 14 '24 | Buy | 41.43 | 10,000 | 414,300 | 37,981 | May 15 05:30 PM | Global GP LLC | General Partner | May 13 '24 | Buy | 42.66 | 10,000 | 426,600 | 27,981 | May 15 05:30 PM | Hanson Gregory B. | Chief Financial Officer | Feb 28 '24 | Option Exercise | 0.00 | 4,626 | 0 | 25,868 | Feb 29 04:34 PM | Geary Sean T. | Chief Legal Officer & Sec. | Feb 28 '24 | Option Exercise | 0.00 | 4,075 | 0 | 23,970 | Feb 29 04:33 PM |
|
|
|
|
Market Cap | 501.15M | EPS (ttm) | -2.88 |
P/E | - | EPS this Y | 17.60% |
Forward P/E | - | EPS next Y | -10.82% |
PEG | - | EPS past 5Y | -67.06% |
P/S | 31.22 | EPS next 5Y | - |
P/B | 0.92 | EPS Q/Q | 30.31% |
Dividend | - | Sales Q/Q | 305.63% |
Insider Own | 30.09% | Inst Own | 83.03% |
Insider Trans | 0.31% | Inst Trans | 24.11% |
Short Float | 30.12% | Earnings | May 08/b |
Analyst Recom | 1.36 | Target Price | 26.89 |
Avg Volume | 1.37M | 52W Range | 5.84 - 21.42 |
|
|
|
Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ashe Andrew D. | See Remarks | May 14 '24 | Buy | 6.26 | 76,000 | 475,760 | 342,509 | May 15 05:30 PM | Nickerson Joan | Chief Administrative Officer | Apr 02 '24 | Sale | 8.24 | 1,514 | 12,475 | 8,659 | Apr 03 05:00 PM | Dorval Allison | Chief Financial Officer | Nov 29 '23 | Sale | 11.45 | 554 | 6,343 | 4,060 | Dec 01 04:30 PM |
|
|
|
|
Market Cap | 97.90M | EPS (ttm) | -0.54 |
P/E | - | EPS this Y | -4.71% |
Forward P/E | - | EPS next Y | -3.60% |
PEG | - | EPS past 5Y | 27.88% |
P/S | 11.59 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -11.01% |
Dividend | - | Sales Q/Q | 5650.00% |
Insider Own | 15.82% | Inst Own | 23.50% |
Insider Trans | 4.89% | Inst Trans | -7.09% |
Short Float | 0.54% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 5.20 |
Avg Volume | 378.69K | 52W Range | 0.65 - 2.12 |
|
|
|
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
YERXA BENJAMIN R | Director | May 15 '24 | Buy | 1.31 | 7,813 | 10,235 | 17,957 | May 15 05:28 PM | Gibney Anthony S | Director | Apr 18 '24 | Buy | 1.30 | 93,290 | 121,277 | 100,000 | Apr 19 09:45 AM | Gibney Anthony S | Director | Apr 17 '24 | Buy | 1.25 | 6,710 | 8,388 | 6,710 | Apr 19 09:45 AM | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | Mar 20 '24 | Buy | 1.60 | 30,000 | 48,000 | 30,000 | Mar 20 04:30 PM | WHITMORE BRADFORD T | 10% Owner | Feb 07 '24 | Buy | 1.35 | 444,444 | 599,999 | 4,495,034 | Feb 09 01:00 PM |
|
|
| |
|
Market Cap | 1.94B | EPS (ttm) | 0.12 |
P/E | 114.05 | EPS this Y | 522.22% |
Forward P/E | 25.00 | EPS next Y | 87.85% |
PEG | - | EPS past 5Y | - |
P/S | 0.50 | EPS next 5Y | - |
P/B | 2.96 | EPS Q/Q | 171.29% |
Dividend | - | Sales Q/Q | 30.04% |
Insider Own | 12.20% | Inst Own | 64.04% |
Insider Trans | 0.07% | Inst Trans | -0.23% |
Short Float | 15.11% | Earnings | May 02/a |
Analyst Recom | 3.60 | Target Price | 11.63 |
Avg Volume | 2.63M | 52W Range | 7.17 - 15.60 |
|
|
|
Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rizik Matthew | Director | May 15 '24 | Buy | 14.50 | 300 | 4,350 | 700,284 | May 15 05:27 PM | Rizik Matthew | Director | May 10 '24 | Buy | 13.68 | 311 | 4,254 | 699,984 | May 10 05:23 PM | Rizik Matthew | Director | May 09 '24 | Buy | 13.86 | 30 | 416 | 699,673 | May 10 05:23 PM | Rizik Matthew | Director | May 08 '24 | Buy | 13.68 | 313 | 4,282 | 699,643 | May 08 08:41 PM | Rizik Matthew | Director | May 02 '24 | Buy | 12.33 | 97 | 1,196 | 699,330 | May 03 06:00 PM |
|
|
|
|
Market Cap | 983.70M | EPS (ttm) | -0.80 |
P/E | - | EPS this Y | -12.12% |
Forward P/E | - | EPS next Y | 35.81% |
PEG | - | EPS past 5Y | - |
P/S | 241.10 | EPS next 5Y | - |
P/B | 16.41 | EPS Q/Q | -85.29% |
Dividend | - | Sales Q/Q | 26.02% |
Insider Own | 74.07% | Inst Own | 20.82% |
Insider Trans | 0.91% | Inst Trans | -7.95% |
Short Float | 36.55% | Earnings | May 08/a |
Analyst Recom | 1.67 | Target Price | 12.00 |
Avg Volume | 974.27K | 52W Range | 2.12 - 9.50 |
|
|
|
NextNav, Inc. develops next-generation positioning, navigation, and timing solutions. Through its Pinnacle system, it provides floor-level altitude service to devices with a barometric pressure sensor. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in McLean, VA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SUBIN NEIL S | Director | May 15 '24 | Buy | 7.62 | 50,000 | 381,000 | 2,265,213 | May 15 05:20 PM | SUBIN NEIL S | Director | May 14 '24 | Buy | 7.69 | 42,761 | 328,832 | 2,215,213 | May 15 05:20 PM | Gates Christian D. | Chief Financial Officer | May 14 '24 | Sale | 7.66 | 24,831 | 190,205 | 824,985 | May 15 05:24 PM | Shams Sammaad | Chief Accounting Officer | May 14 '24 | Sale | 7.72 | 6,649 | 51,330 | 63,588 | May 15 05:22 PM | SUBIN NEIL S | Director | May 13 '24 | Buy | 7.52 | 57,239 | 430,437 | 2,172,452 | May 15 05:20 PM |
|
|
| |
|
Market Cap | 13.16B | EPS (ttm) | 7.16 |
P/E | 6.89 | EPS this Y | -6.49% |
Forward P/E | 6.69 | EPS next Y | 14.51% |
PEG | 0.77 | EPS past 5Y | 7.25% |
P/S | 1.24 | EPS next 5Y | 9.00% |
P/B | 1.29 | EPS Q/Q | -36.86% |
Dividend | 2.44% | Sales Q/Q | -3.95% |
Insider Own | 4.09% | Inst Own | 80.85% |
Insider Trans | -1.10% | Inst Trans | -3.27% |
Short Float | 1.81% | Earnings | May 07/a |
Analyst Recom | 1.88 | Target Price | 62.81 |
Avg Volume | 3.20M | 52W Range | 32.07 - 55.95 |
|
|
|
Ovintiv, Inc. engages in the production and development of oil, natural gas liquids and natural gas producing plays. The firm operates through the following segments: Canadian Operations, USA Operations, and Market Optimization. The Canadian Operations segment includes the exploration for, development of, and production of oil, NGLs, natural gas and other related activities within Canada. The USA Operations segment includes the exploration for, development of, and production of oil, NGLs, natural gas and other related activities within the United States. The Market Optimization segment's activities are managed by the Midstream, Marketing & Fundamentals team, which is responsible for the sale of the company's proprietary production to third party customers. The company was founded in 1881 and is headquartered in Denver, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Chhina Sippy | Director | May 14 '24 | Buy | 49.50 | 1,600 | 79,200 | 1,600 | May 15 05:19 PM | NANCE STEVEN W | Director | May 13 '24 | Sale | 50.00 | 12,000 | 600,000 | 8,929 | May 15 05:42 PM | Zemljak Renee Ellen | EVP, Midstream, Mrktg & Fndmtl | Mar 14 '24 | Sale | 50.96 | 76,264 | 3,886,413 | 23,672 | Mar 14 04:59 PM | Zemljak Renee Ellen | EVP, Midstream, Mrktg & Fndmtl | Mar 12 '24 | Option Exercise | 35.80 | 10,039 | 359,396 | 109,975 | Mar 14 04:59 PM | Moore Rachel Maureen | EVP, Corporate Services | Mar 01 '24 | Sale | 50.65 | 9,300 | 471,045 | 52,557 | Mar 04 06:57 PM |
|
|
|
|
Market Cap | 755.12M | EPS (ttm) | 2.71 |
P/E | 18.79 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -7.81% |
P/S | 4.43 | EPS next 5Y | - |
P/B | 1.18 | EPS Q/Q | -30.94% |
Dividend | 4.17% | Sales Q/Q | 9.92% |
Insider Own | 24.20% | Inst Own | 12.67% |
Insider Trans | 0.79% | Inst Trans | - |
Short Float | 1.56% | Earnings | Apr 26/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 18.85K | 52W Range | 42.91 - 85.00 |
|
|
May-15-24 10:11AM
|
Is Burke & Herbert Bank & Trust Co (NASDAQ:BHRB) the Best Financial Dividend Stock Insiders are Buying in 2024?
(Insider Monkey) |
08:50AM
|
10 Best Financial Dividend Stocks Insiders are Buying in 2024
(Insider Monkey) |
May-13-24 09:54AM
|
BHRB Stock Earnings: Burke & Herbert Financial Reported Results for Q4 2023
(InvestorPlace) |
May-03-24 07:30AM
|
Burke & Herbert Financial Services Corp. Completes Merger of Equals with Summit Financial Group, Inc.
(PR Newswire) +5.92% |
Apr-26-24 01:53PM
|
BHRB Stock Earnings: Burke & Herbert Financial Reported Results for Q1 2024
(InvestorPlace) |
08:30AM
|
Burke & Herbert Financial Services Corp. Announces First Quarter 2024 Results and Declares Common Stock Dividend
(PR Newswire) |
Apr-19-24 08:30AM
|
Burke & Herbert Financial Services Corp. and Summit Financial Group, Inc. Announce Receipt of Regulatory Approvals and Closing Date for Merger of Equals
(PR Newswire) |
Feb-01-24 12:02PM
|
Hedge Fund and Insider Trading News: David Einhorn, Crispin Odey, Bill Ackman, Stanley Druckenmiller, Ken Griffin, Burke Herbert Financial Services (BHRB), KalVista Pharmaceuticals, Inc. (KALV), and More
(Insider Monkey) |
Jan-26-24 08:00AM
|
Burke & Herbert Financial Services Corp. Announces Fourth Quarter and Full Year 2023 Results and Declares Common Stock Dividend
(PR Newswire) |
Dec-06-23 02:07PM
|
Burke & Herbert Financial Services Corp. and Summit Financial Group, Inc. Announce Receipt of Shareholder Approval for Merger
(PR Newswire) |
|
Burke Herbert Financial Services Corp. is a bank holding company, which engages in the provision of banking products and financial services to small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals. It operates through the following loan portfolio segments: Commercial Real Estate, Owner-Occupied Commercial Real Estate, Acquisition, Construction, and Development, Commercial and Industrial, Single Family Residential (1-4 Units), and Consumer Non-Real Estate and Other. The Commercial Real Estate segment includes leasing of the real estate collateral or income generated from the sale of the collateral. The Owner-Occupied Commercial Real Estate segment focuses on the operations of the business that occupies the property and the value of the collateral. The Acquisition, Construction, and Development segment offers creditworthiness of the borrower, project completion within budget, sale after completion, and the value of the collateral. The Commercial and Industrial segment is involved in the operations of the business and the value of the collateral. The Single Family Residential (1-4 Units) segment provides loans for investment purpose carry risk associated with the continued creditworthiness of the borrower, the value of the collateral, and either the net operating income generated from the lease of the real estate collateral or income generated from the sale of the collateral. The Consumer Non-Real Estate and Other segment covers loans carry risk associated with the creditworthiness of the borrower and the value of the collateral. The company was founded on September 14, 2022 and is headquartered in Alexandria, VA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
HINKLE GARY L | Director | May 15 '24 | Buy | 50.23 | 600 | 30,135 | 219,450 | May 15 05:17 PM | HINKLE GARY L | Director | May 14 '24 | Buy | 49.50 | 2,779 | 137,560 | 218,850 | May 14 03:15 PM | HINKLE GARY L | Director | May 13 '24 | Buy | 49.65 | 613 | 30,435 | 216,071 | May 14 09:33 AM | HINKLE GARY L | Director | May 10 '24 | Buy | 49.60 | 1,608 | 79,757 | 215,458 | May 10 04:33 PM | McLaughlin Shawn Patrick | Director | May 01 '24 | Buy | 52.51 | 850 | 44,634 | 51,850 | May 01 02:33 PM |
|
|
| |
|
Market Cap | 191.38M | EPS (ttm) | -1.47 |
P/E | - | EPS this Y | 25.59% |
Forward P/E | 192.08 | EPS next Y | 112.25% |
PEG | - | EPS past 5Y | - |
P/S | 0.26 | EPS next 5Y | 25.00% |
P/B | 1.22 | EPS Q/Q | -47.93% |
Dividend | - | Sales Q/Q | 2.73% |
Insider Own | 4.47% | Inst Own | 104.76% |
Insider Trans | 271.69% | Inst Trans | -9.67% |
Short Float | 14.89% | Earnings | Mar 19/b |
Analyst Recom | 2.00 | Target Price | 30.75 |
Avg Volume | 88.15K | 52W Range | 14.20 - 32.90 |
|
|
May-03-24 05:42PM
|
Harmonic, Reservoir Media, and More Stocks See Action From Activist Investors
(Barrons.com) |
May-02-24 01:59PM
|
Hedge Fund and Insider Trading News: Simon Sadler, John Paulson, Bill Ackman, Alden Global Capital, Greenlight Capital, Citadel LLC, Point72 Asset Management, CECO Environmental Corp. (CECO), Liberty SiriusXM Group (LSXMA), and More
(Insider Monkey) |
Apr-24-24 01:48PM
|
Hedge Fund and Insider Trading News: Bill Ackman, Appaloosa Management, Marshall Wace LLP, Centuri Holdings Inc (CTRI), Citi Trends, Inc. (CTRN), and More
(Insider Monkey) |
Mar-20-24 10:34AM
|
Citi Trends, Inc. (NASDAQ:CTRN) Q4 2023 Earnings Call Transcript
(Insider Monkey) |
Mar-19-24 11:23PM
|
Q4 2023 Citi Trends Inc Earnings Call
(Thomson Reuters StreetEvents) -6.32% |
03:45PM
|
Citi Trends (CTRN) Q4 2023 Earnings Call Transcript
(Motley Fool) |
10:52AM
|
CTRN Stock Earnings: Citi Trends Misses EPS, Misses Revenue for Q4 2023
(InvestorPlace) |
08:31AM
|
Citi Trends Inc (CTRN) Reports Mixed Fiscal 2023 Results Amidst Economic Challenges
(GuruFocus.com) |
07:02AM
|
Citi Trends: Fiscal Q4 Earnings Snapshot
(Associated Press Finance) |
06:45AM
|
Citi Trends Announces Fourth Quarter and Fiscal 2023 Results
(Business Wire) |
|
Citi Trends, Inc. engages in the retail of urban fashion apparel, accessories, and home trends. It offers products under its Citi Steps and Red Ape brands. The company was founded in 1946 and is headquartered in Savannah, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Fund 1 Investments, LLC | 10% Owner | May 15 '24 | Buy | 24.07 | 15,785 | 379,954 | 2,027,163 | May 15 05:03 PM | Fund 1 Investments, LLC | 10% Owner | May 14 '24 | Buy | 24.19 | 4,000 | 96,775 | 2,011,378 | May 15 05:03 PM | Fund 1 Investments, LLC | 10% Owner | May 13 '24 | Buy | 23.48 | 5,481 | 128,704 | 2,007,378 | May 15 05:03 PM | Fund 1 Investments, LLC | 10% Owner | May 07 '24 | Buy | 23.18 | 9,500 | 220,168 | 2,001,897 | May 07 05:36 PM | Fund 1 Investments, LLC | 10% Owner | May 06 '24 | Buy | 22.76 | 6,330 | 144,084 | 1,992,397 | May 07 05:36 PM |
|
|
|
|
Market Cap | 1.13B | EPS (ttm) | 0.98 |
P/E | 28.50 | EPS this Y | 16.44% |
Forward P/E | 12.52 | EPS next Y | 9.58% |
PEG | 3.05 | EPS past 5Y | -11.71% |
P/S | 1.25 | EPS next 5Y | 9.34% |
P/B | 1.68 | EPS Q/Q | 5.87% |
Dividend | 0.58% | Sales Q/Q | 5.40% |
Insider Own | 1.82% | Inst Own | 98.50% |
Insider Trans | 3.59% | Inst Trans | -0.13% |
Short Float | 5.36% | Earnings | Apr 30/b |
Analyst Recom | 2.50 | Target Price | 40.00 |
Avg Volume | 259.30K | 52W Range | 22.59 - 29.07 |
|
|
|
TriMas Corp. engages in the manufacture of industrial products for customers in the consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas end markets. It operates through the following segments: Packaging, Aerospace, and Specialty Products. The Packaging segment designs and manufactures dispensing products, including foaming pumps, lotion and hand soap pumps, sanitizer pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers, polymeric and steel caps and closures, including food lids, flip-top closures, child resistant caps, drum and pail closures, and flexible spouts, polymeric jar products, and fully integrated dispensers for fill-ready bag-in-box applications, all for a variety of consumer product markets including, but not limited to, beauty and personal care, home care, food and beverage, and pharmaceutical and nutraceutical, as well as the industrial market. The Aerospace segment is involved in the design and manufacture of precision fasteners, tubular products and assemblies for fluid conveyance, and machined products and assemblies to serve the aerospace and defense market under the brand name Monogram Aerospace Fasteners, RSA Engineered Products and Martinic Engineering, Allfast Fastening Systems, and Mac Fasteners. The Specialty Products segment designs, manufactures, and distributes highly-engineered steel cylinders, wellhead engines, and compression systems for use within industrial markets and includes the Norris Cylinder and Arrow Engine brands. The company was founded by Brian P. Campbell in 1986 and is headquartered in Bloomfield Hills, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Tredwell Daniel P | Director | May 10 '24 | Buy | 26.80 | 81 | 2,168 | 50,842 | May 15 04:45 PM | Parker Herbert K | Director | May 08 '24 | Buy | 26.27 | 6,000 | 157,597 | 51,157 | May 08 06:10 PM | Parker Herbert K | Director | May 07 '24 | Buy | 26.01 | 6,000 | 156,060 | 45,157 | May 08 06:10 PM | Parker Herbert K | Director | May 06 '24 | Buy | 26.52 | 6,100 | 161,789 | 39,157 | May 08 06:10 PM | Parker Herbert K | Director | May 03 '24 | Buy | 26.34 | 1,500 | 39,512 | 33,057 | May 03 05:28 PM |
|
|
|
|
Market Cap | 5.80M | EPS (ttm) | -0.78 |
P/E | - | EPS this Y | 64.94% |
Forward P/E | - | EPS next Y | 14.81% |
PEG | - | EPS past 5Y | -189.86% |
P/S | 12.09 | EPS next 5Y | - |
P/B | 2.10 | EPS Q/Q | 12.10% |
Dividend | - | Sales Q/Q | 23.58% |
Insider Own | 51.01% | Inst Own | 4.99% |
Insider Trans | 1.70% | Inst Trans | - |
Short Float | 0.86% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 2.00 |
Avg Volume | 62.23K | 52W Range | 0.64 - 2.71 |
|
|
|
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kaufman Jonathan H | See remarks below. | May 14 '24 | Buy | 0.76 | 10,000 | 7,590 | 898,849 | May 15 04:39 PM | Kaufman Jonathan H | See remarks below. | Mar 19 '24 | Buy | 0.87 | 25,000 | 21,802 | 888,849 | Mar 19 06:21 PM | Kaufman Jonathan H | See remarks below. | Mar 18 '24 | Buy | 0.79 | 30,000 | 23,649 | 863,849 | Mar 19 06:21 PM |
|
|
|